Skip to Content

Join the 'Soriatane' group to help and get support from people like you.

Soriatane News

Whites More Likely Than Others to Seek Help for Psoriasis

Posted 29 Dec 2017 by Drugs.com

THURSDAY, Dec. 28, 2017 – Among people with the skin disease psoriasis, could skin color play a role in whether or not they visit a dermatologist? An analysis of federal government health survey data from 2001 to 2013 found that black, Asian and other minorities are less likely than white people in the United States to see a doctor for treatment of the chronic inflammatory disease. The ...

Severe Psoriasis May Make Diabetes Increasingly Likely

Posted 20 Nov 2017 by Drugs.com

MONDAY, Nov. 20, 2017 – People with the skin disease psoriasis are at increased risk for type 2 diabetes, and the more severe the psoriasis, the greater their risk, a new study finds. Researchers examined data on nearly 85,000 adults in the United Kingdom, including 8,100 who had psoriasis. Compared with people who did not have psoriasis, the risk for diabetes was 21 percent higher among those ...

Cyndi Lauper's Psoriasis Battle Shows Her 'True Colors'

Posted 25 Oct 2017 by Drugs.com

WEDNESDAY, Oct. 25, 2017 – With her pink tresses and eye-catching stage costumes, pop culture icon Cyndi Lauper was never one to hide. But that's exactly what she wanted to do when she developed psoriasis, which spread to most of her body and sapped her strength before the skin disorder was controlled. Appearing first on her scalp and later covering everything except her face, psoriasis struck ...

Severe Psoriasis Linked to Higher Risk of Earlier Death

Posted 5 Sep 2017 by Drugs.com

TUESDAY, Sept. 5, 2017 – People with severe cases of the skin disease psoriasis appeared to have almost double the risk of dying during a four-year study than people without the condition, research suggests. But the increased death rate was only seen in those with psoriasis affecting more than 10 percent of their body surface area. For those with less-severe disease, the risk of dying early was ...

Siliq Approved for Plaque Psoriasis

Posted 2 Mar 2017 by Drugs.com

THURSDAY, Feb. 16, 2017 – The injected drug Siliq (brodalumab) has been approved by the U.S. Food and Drug Administration to treat moderate-to-severe plaque psoriasis in adults. Siliq is approved for patients who've already failed to respond to other systemic therapies, the agency noted. The autoimmune disease – so-called because the immune system produces antibodies that attack the body's own ...

FDA Approves Injectable Psoriasis Drug Siliq for Tough Cases

Posted 16 Feb 2017 by Drugs.com

THURSDAY, Feb. 16, 2017 – A new drug to treat tough cases of the skin condition psoriasis has won approval from the U.S. Food and Drug Administration. Valeant Pharmaceuticals' injectable drug Siliq (brodalumab) was approved for adults with moderate-to-severe psoriasis that isn't responding to other recommended treatments. However, the drug carries a warning about increased risk for suicidal ...

Health Tip: Acne Has Lasting Effects

Posted 15 Dec 2015 by Drugs.com

-- Acne may be most visible on the skin, but for many people, its effects are greater than just temporary blemishes. Acne can lead to these physical and emotional issues, says the American Academy of Dermatology: Developing poor self-esteem and isolation. Developing depression, which can become severe. Developing dark spots that remain after acne has cleared. These may last for months or years. ...

Worse Psoriasis, Less Healthy Arteries, Study Finds

Posted 8 Oct 2015 by Drugs.com

THURSDAY, Oct. 8, 2015 – The skin disorder psoriasis appears linked with artery inflammation, raising the odds for heart disease, a new study says. "As the amount of psoriasis increases, the amount of blood vessel inflammation increases," said senior investigator Dr. Nehal Mehta, a clinical investigator with the U.S. National Heart, Lung, and Blood Institute. His team also found that even mild ...

Newer Psoriasis Drugs May Lower Heart Attack Risk for Patients

Posted 20 Aug 2012 by Drugs.com

MONDAY, Aug. 20 – People with psoriasis who take a new class of drugs known as tumor necrosis factor (TNF) inhibitors may be at a lower risk for heart attack than their counterparts who only use topical medications to treat this inflammatory skin condition, a new study shows. And patients taking older systemic medicines and phototherapy may also have a reduced heart attack risk compared to those ...

Acne, Psoriasis Meds Don't Raise Fracture Risk

Posted 17 May 2010 by Drugs.com

MONDAY, May 17 – Patients who take drugs like Accutane and Soriatane for acne and psoriasis don't seem to be at higher risk of breaking bones, a new study finds, even though similar dietary supplements have been linked to fractures. Accutane and Soriatane – known generically as isotretinoin and acitretin – are similar to vitamin A, which has been linked to broken bones when taken in high ...

Ask a Question

Further Information

Related Condition Support Groups

Psoriasis

Soriatane Patient Information at Drugs.com